NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Clinical trial NCT00206180 · COMPLETED

Trial details

NCT number: NCT00206180
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Erosive Esophagitis Reflux Esophagitis Gastroesophageal Reflux Disease

Start date: 2004-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.